4B-MAR

4'-Bromo-4-methylaminorex
Identifiers
	IUPAC name 4-methyl-5-(4-bromophenyl)-4,5-dihydro-1,3-oxazol-2-amine;
CAS Number	none;
PubChem CID	165361748;
Chemical and physical data
Formula	C10H11BrN2O
Molar mass	255.115 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CC1C(OC(=N1)N)C2=CC=C(C=C2)Br;
	InChI InChI=1S/C10H11BrN2O/c1-6-9(14-10(12)13-6)7-2-4-8(11)5-3-7/h2-6,9H,1H3,(H2,12,13); Key:TUHDNALAVIDYHT-UHFFFAOYSA-N;

4'-Bromo-4-methylaminorex (4B-MAR, 4'-Br-4-MAR) is a designer drug from the substituted aminorex family, first definitively identified in Austria in January 2022. Its pharmacological activity has not been reported, but it is believed to have stimulant effects.^[1]

References

^ Seibert E, Kunert O, Pferschy-Wenzig EM, Schmid MG (September 2022). "Characterization of Three Novel 4-Methylaminorex Derivatives Applied as Designer Drugs". Molecules. 27 (18). Basel, Switzerland: 5770. doi:10.3390/molecules27185770. PMC 9503756. PMID 36144500.

This pharmacology-related article is a stub. You can help Wikipedia by expanding it.

[pmid36144500-1] Seibert E, Kunert O, Pferschy-Wenzig EM, Schmid MG (September 2022). "Characterization of Three Novel 4-Methylaminorex Derivatives Applied as Designer Drugs". Molecules. 27 (18). Basel, Switzerland: 5770. doi:10.3390/molecules27185770. PMC 9503756. PMID 36144500.

[1]

See also

References